Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.
Cancer cells differentiate along specific lineages that largely determine their clinical and biologic behavior. Distinct cancer phenotypes from different cells and organs likely result from unique gene expression repertoires established in the embryo and maintained after malignant transformation. We used comprehensive gene expression analysis to examine this concept in the prostate, an organ with a tractable developmental program and a high propensity for cancer. We focused on gene expression in the murine prostate rudiment at three time points during the first 48 h of exposure to androgen, which initiates proliferation and invasion of prostate epithelial buds into surrounding urogenital sinus mesenchyme. Here, we show that androgen exposure regulates genes previously implicated in prostate carcinogenesis comprising pathways for the phosphatase and tensin homolog (PTEN), fibroblast growth factor (FGF)/mitogen-activated protein kinase (MAPK), and Wnt signaling along with cellular programs regulating such 'hallmarks' of cancer as angiogenesis, apoptosis, migration and proliferation. We found statistically significant evidence for novel androgen-induced gene regulation events that establish and/or maintain prostate cell fate. These include modulation of gene expression through microRNAs, expression of specific transcription factors, and regulation of their predicted targets. By querying public gene expression databases from other tissues, we found that rather than generally characterizing androgen exposure or epithelial budding, the early prostate development program more closely resembles the program for human prostate cancer. Most importantly, early androgen-regulated genes and functional themes associated with prostate development were highly enriched in contrasts between increasingly lethal forms of prostate cancer, confirming a 'reactivation' of embryonic pathways for proliferation and invasion in prostate cancer progression. Among the genes with the most significant links to the development and cancer, we highlight coordinate induction of the transcription factor Sox9 and suppression of the proapoptotic phospholipid-binding protein Annexin A1 that link early prostate development to early prostate carcinogenesis. These results credential early prostate development as a reliable and valid model system for the investigation of genes and pathways that drive prostate cancer.
Schaeffer
E M
EM
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Marchionni
L
L
Huang
Z
Z
Simons
B
B
Blackman
A
A
Yu
W
W
Parmigiani
G
G
Berman
D M
DM
D000728:Androgens / Q000378:metabolism*; D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D047108:Embryonic Development / Q000235:genetics*; D004847:Epithelial Cells / Q000166:cytology; D005455:Fluorescent Antibody Technique; D015870:Gene Expression; D020869:Gene Expression Profiling; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011467:Prostate / Q000196:embryology*; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D046888:Tissue Array Analysis
D000728:Androgens
Exp Biol Med (Maywood). 2006 Jan;231(1):20-7
16380641
Cancer Cell. 2007 Dec;12(6):572-85
18068633
Curr Biol. 2005 Apr 26;15(8):702-13
15854902
Am J Physiol Heart Circ Physiol. 2007 Mar;292(3):H1278-90
17071732
Prostate Cancer Prostatic Dis. 2005;8(1):7-13
15477876
Clin Cancer Res. 2002 Jan;8(1):117-23
11801547
Nat Methods. 2005 May;2(5):345-50
15846361
Nature. 2002 Aug 22;418(6900):823
12192390
Reproduction. 2001 Feb;121(2):187-95
11226043
Dev Biol. 2004 Mar 15;267(2):387-98
15013801
Cancer Res. 2007 Jul 15;67(14):6535-8
17638861
Cold Spring Harb Symp Quant Biol. 2003;68:227-35
15338622
Nat Genet. 2007 Jan;39(1):41-51
17173048
Urol Oncol. 2006 May-Jun;24(3):231-6
16678055
Gene Expr Patterns. 2006 Mar;6(3):310-24
16378759
Nature. 1986 Oct 16-22;323(6089):643-6
2877398
Nature. 1976 Mar 11;260(5547):170-3
176594
Cancer Lett. 2006 Jun 8;237(1):22-32
16023783
Proc Natl Acad Sci U S A. 2003 Sep 30;100 Suppl 1:11896-903
12909713
Dev Biol. 2007 Nov 1;311(1):124-35
17904116
Histochem Cell Biol. 2001 Nov;116(5):427-39
11735006
Nat Rev Mol Cell Biol. 2008 Mar;9(3):219-30
18270516
Genes Dev. 2004 Mar 15;18(6):629-40
15075291
Differentiation. 2007 Mar;75(3):219-34
17288544
Trends Mol Med. 2002 Jan;8(1):17-23
11796262
Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2563-8
16284379
Cancer Cell. 2007 Dec;12(6):559-71
18068632
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15149-54
11742071
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):181-6
17185413
Biol Reprod. 1980 Feb;22(1):9-17
6991014
Behav Brain Res. 2001 Nov 1;125(1-2):279-84
11682119
Proc Natl Acad Sci U S A. 2005 May 10;102(19):6942-7
15860580
Prostate. 1987;11(3):229-42
3684783
Dev Biol. 2004 Sep 15;273(2):418-35
15328023
Genes Dev. 1999 Apr 15;13(8):966-77
10215624
Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):811-6
14711987
Cytokine Growth Factor Rev. 2005 Apr;16(2):107-37
15863029
Perspect Biol Med. 1968 Spring;11(3):371-5
5704208
Genome Biol. 2004;5(10):R80
15461798
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
16199517
Recent Prog Horm Res. 2002;57:385-409
12017554
J Clin Oncol. 2005 Nov 10;23(32):8253-61
16278481
Nat Rev Cancer. 2006 Aug;6(8):593-602
16862190
Cancer Res. 2007 Jan 15;67(2):528-36
17234760
J Biol Chem. 2003 Sep 5;278(36):34226-36
12815063
J Dent Res. 2005 Feb;84(2):160-5
15668334
Cancer Res. 2008 Jan 15;68(2):444-9
18199538
Cell Res. 2005 Jan;15(1):28-32
15686623
Cancer Cell. 2003 Sep;4(3):209-21
14522255
Cell. 2000 Jan 7;100(1):57-70
10647931
Cancer Cell. 2003 Jun;3(6):537-49
12842083
Cell. 2001 Mar 9;104(5):719-30
11257226
Oncogene. 1999 May 6;18(18):2883-91
10362259
Nature. 2007 Dec 6;450(7171):893-8
17982442
Dev Biol. 2003 Sep 1;261(1):39-54
12941620
Cancer Res. 2005 Nov 15;65(22):10423-30
16288033
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D277-80
14681412
Cancer Res. 1999 Sep 1;59(17):4291-6
10485474
Mod Pathol. 2004 Mar;17(3):360-79
14739906
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Dev Biol. 2008 Apr 15;316(2):302-11
18325490
Arch Histol Cytol. 2004 Dec;67(5):417-34
15781983